Literature DB >> 13460865

The clinical investigation of pacatal in open psychiatric settings.

G J SARWER-FONER, E K KORANYI.   

Abstract

Entities:  

Keywords:  AUTONOMIC DRUGS/effects; PHENOTHIAZINE/related compounds

Mesh：

Substances：

Year:  1957        PMID： 13460865      PMCID： PMC1824492     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  12 in total

1.  Pacatal.

Authors:  M BRAUN
Journal:  Am J Psychiatry       Date:  1957-03       Impact factor: 18.112

2.  Fatal agranulocytosis during treatment with pacatal.

Authors:  P E FELDMAN; J BERTONE; H PANTHEL
Journal:  Am J Psychiatry       Date:  1957-03       Impact factor: 18.112

3.  The ataractic drugs: the present position of chlorpromazine, frenquel, pacatal, and reserpine in the psychiatric hospital.

Authors:  H A BOWENS
Journal:  Am J Psychiatry       Date:  1956-12       Impact factor: 18.112

4.  Effects of pacatal on symptoms in chronic psychotic female in-patients.

Authors:  A KING; P H MITCHELL; P SYKES
Journal:  Br Med J       Date:  1957-01-26

5.  A comparative study of various ataractic drugs.

Authors:  P E FELDMAN
Journal:  Am J Psychiatry       Date:  1957-01       Impact factor: 18.112

6.  [Phenothiazine derivative P 391 in potentiated anesthesia].

Authors:  K HORATZ
Journal:  Anaesthesist       Date:  1954-08       Impact factor: 1.041

7.  The use of reserpine in an open psychiatric setting.

Authors:  G J SARWER-FONER; W OGLE
Journal:  Can Med Assoc J       Date:  1955-08-01       Impact factor: 8.262

8.  [Lacumin therapy in severe mental disorders].

Authors:  H WERENBERG
Journal:  Nord Med       Date:  1955-12-01

9.  [Pharmacological studies on N-alkyl-piperidyl-phenothiazine derivatives].

Authors:  O NIESCHULZ; K POPENDIKER; K H SACK
Journal:  Arzneimittelforschung       Date:  1954-04

10.  [Circulatory and metabolic problems in application of phenothiazine derivatives in sleep therapy].

Authors:  H KLEINSORGE
Journal:  Arztl Wochensch       Date:  1954-03-19
View more
  4 in total

1.  Recognition and management of drug-induced extra-pyramidal reactions and "paradoxical" behavioural reactions in psychiatry.

Authors:  G J SARWER-FONER
Journal:  Can Med Assoc J       Date:  1960-08-13       Impact factor: 8.262

2.  Depressive states and drugs. III. Use of methylphenidate (Ritalin) in open psychiatric settings and in office practice.

Authors:  A B KERENYI; E K KORANYI; G J SARWER-FONER
Journal:  Can Med Assoc J       Date:  1960-12-10       Impact factor: 8.262

3.  Depressive states and drugs. II. The study of phenelzine dihydrogen sulfate (nardil) in open psychiatric settings.

Authors:  G J SARWER-FONER; E K KORANYI; A MESZAROS; H GRAUER
Journal:  Can Med Assoc J       Date:  1959-12-15       Impact factor: 8.262

4.  Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis.

Authors:  Conor Mc Guire; Lynn Elton; Peter Wieghofer; Jens Staal; Sofie Voet; Annelies Demeyer; Daniel Nagel; Daniel Krappmann; Marco Prinz; Rudi Beyaert; Geert van Loo
Journal:  J Neuroinflammation       Date:  2014-07-21       Impact factor: 8.322
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.